FDA approves Bristol-Myers leukemia drug Sprycel

Posted by rob on June 29, 2006 under Uncategorized | Be the First to Comment

FDA approves Bristol-Myers leukemia drug Sprycel
MarketWatch - 3 hours ago
The drug, dasatinib, would be sold under the brand name Sprycel. Bristol-Myers said Sprycel should be available nationwide within days.
Drug stocks climb, Bristol-Myers gains on Sprycel approval MarketWatch
FDA Okays Sprycel for CML Resistant or Intolerant to Gleevec MedPage Today
Bristol-Myers Squibb Announces FDA Approval Of SPRYCEL With Two Trading Markets
FDA.gov - TheStreet.com - all 73 related »

Add A Comment

You must be logged in to post a comment.